grant

Age Related Hearing Loss and Vestibular Dysfunction

Organization VETERANS HEALTH ADMINISTRATIONLocation ANN ARBOR, UNITED STATESPosted 1 Oct 2023Deadline 30 Sept 2027
VANIHUS FederalResearch GrantFY202565 and older65 or older65 years of age and older65 years of age or more65 years of age or older65+ years65+ years oldAbnormal gaitAccelerationAcoustic Evoked Brain Stem PotentialsAcoustic Evoked Brainstem PotentialsAffectAgeAge MonthsAge YearsAged 65 and OverAgingAmentiaAmericanAppearanceAquadiolAuditory Brain Stem ResponsesAuditory systemAwardCell BodyCellsCessation of lifeClinicalCommon Rat StrainsCommunicationCorti CellDeathDementiaDetectionDevelopmentDiagnosisDietDimenformonDiogynDiogynetsDiseaseDisorderDizzinessDrug TherapyElementsEquilibriumEstraceEstradiolEstradiol-17 betaEstradiol-17betaEstraldineEstrogensEvoked PotentialsExposure toGait abnormalityGait disorderGait disturbancesGait dysfunctionGait impairmentGulf WarHair CellsHeadHearing AidsHearing LossHumanHypoacusesHypoacusisIncidenceIncrease lifespanInjuryInner Ear DisorderInterventionJobsKnowledgeLifeMeasuresMental DepressionMiceMice MammalsMissionModern ManMurineMusNational Institute of AgingNational Institute on AgingNoiseNon-pharmacologic TherapyNonpharmacologic InterventionNonpharmacologic TherapyNonpharmacologic approachNonpharmacologic treatmentNursing HomesOccupationsOperation Desert ShieldOperation Desert StormOvocyclinOvocylinPatient CarePatient Care DeliveryPersonsPharmacological TreatmentPharmacotherapyPhysiatric ProcedurePhysical Medicine ProcedurePhysical TherapeuticsPhysical therapyPhysiotherapyPilot ProjectsPositionPositioning AttributePresbyacusisPresbycusisProfessional PositionsProgynonQOLQuality of lifeRapamuneRapamycinRatRats MammalsRattusReflexReflex actionReportingResponse LatenciesRiskRisk ReductionRodent ModelSensoryServicesSignal PathwaySirolimusSynapsesSynapticTestingTherapeutic EstradiolTherapeutic EstrogenTimeTrainingTranslationsVestibularVestibular System ImpairmentVestibular defectVestibular dysfunctionVestibular problemsVeteransWalking impairmentYouthYouth 10-21above age 65adult youthafter age 65age 65 and greaterage 65 and olderage 65 or olderageage associatedage associated alterationsage associated changesage associated diseaseage associated disorderage associated hearing lossage associated impairmentage correlatedage correlated alterationsage correlated changesage dependentage dependent alterationsage dependent changesage dependent diseaseage dependent disorderage dependent impairmentage induced alterationsage induced changesage induced hearing lossage linkedage of 65 years onwardage relatedage related alterationsage related changesage related decline in hearingage related hearing deficitsage related hearing impairmentage related hearing lossage related human diseaseage specificage specific alterationsage specific changesage-related diseaseage-related disorderage-related impairmentaged 65 and greateraged 65+aged ≥65agesaging associated alterationsaging associated changesaging associated diseaseaging associated disordersaging associated hearing lossaging correlated alterationsaging correlated changesaging dependent alterationsaging dependent changesaging induced alterationsaging induced changesaging induced hearing lossaging related alterationsaging related changesaging related decline in hearingaging related diseaseaging related disordersaging related hearing deficitsaging related hearing impairmentaging related hearing lossaging specific alterationsaging specific changesalterations with ageassistive hearing deviceassistive listening devicebalancebalance disorderbalance functionbalance impairmentboost longevitybrain stem auditory evoked potentialsbrainstem auditory evoked potentialscare for patientscare of patientscaring for patientschanges with ageclinical relevanceclinically relevantcompare treatmentdepressiondevelopmentaldietsdisabilitydisease associated with agingdisease of agingdisorder of agingdisorders associated with agingdisorders related to agingdisturbed balancedrug interventiondrug treatmentdysfunctional hearingear hair cellefficacy testingelongating the lifespanenhance healthspanenhance longevityequilibration disorderequilibrium disorderextend healthspanextend life spanextend lifespanextend longevityextending healthy lifespanfallsfoster longevityhealthspan extensionhearing amplificationhearing assistancehearing assistive devicehearing challengedhearing defecthearing deficienthearing deficithearing devicehearing difficultyhearing dysfunctionhearing impairmenthuman old age (65+)improve healthspanimprove lifespanimprove longevityincrease healthspaninjuriesinner ear diseasesintervention enhancing longevityintervention to extend lifespanintervention to improve lifespanintervention to increase longevityintervention to prolong lifespanintervention to promote longevitylater in lifelater lifelife spanlifespanlifespan extending interventionlifespan extending therapieslifespan extensionlifespan improving interventionlifespan increasing interventionlifespan increasing therapieslifespan interventionlifespan prolonging interventionslifespan promoting interventionlongevity boosting interventionlongevity extending interventionlongevity interventionlongevity promoting interventionlongevity therapylongevity treatmentmid lifemid-lifemiddle agemiddle agedmidlifemilitary veteranmouse modelmurine modelnatural agingnoise exposurenon-drug therapynon-drug treatmentnondrug therapynondrug treatmentnormal agingnormative agingnursing homeotoacoustic emissionover 65 yearspharmaceutical interventionpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticspilot studypreventpreventingprogramsprolong healthspanprolong lifespanprolong longevitypromote healthspanpromote lifespanpromote longevityreduce riskreduce risksreduce that riskreduce the riskreduce these risksreduces riskreduces the riskreducing riskreducing the riskrisk-reducingstrategy to enhance longevitystrategy to promote longevitysupport longevitysynapsetranslationtreatment comparisontreatment effectvestibular deficitvestibular impairmentvestibular systemvestibular system dysfunctionveteran populationyoung adultyoung adult ageyoung adulthoodyouth age≥65 years
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Proposed studies are to test mechanism-based, clinically relevant interventions to meet the challenges of
aging in the Veteran population. Hearing Loss is one of the most common service-related disabilities for those

who served in the gulf wars and age-related hearing loss (ARHL) contributes to this. Our current studies in the

mouse model found that rapamycin significantly delayed / reduced ARHL. Our preliminary now show potential

for 17-α-estradiol as another treatment option that acts on a different functional signaling pathway. Aim 1A will

test 17-α-estradiol treatment for ARHL and Aim 1B will examine if a combination of rapamycin and 17-α-

estradiol treatments increases overall efficacy over either alone.

Noise and Aging are the two most common causes of hearing loss and for many Veterans ARHL will

superimpose on an auditory system already compromised by noise exposure during their service. Our current

studies found that noise exposure during youth significantly accelerated and increased ARHL and our pilot

studies suggest rapamycin treatment starting shortly after the noise exposure can significantly reduce this

noise enhancement of ARHL. Aim 1C will test efficacy of rapamycin treatment starting later in life (more

pertinent to treatment of Veterans) shortly before noise acceleration would appear.

Balance and gait disorders effect millions of Americans and become worse with aging. We hypothesize that

inner age aging disorders share sufficient underlying mechanisms such that the treatments we have shown

to delay / reduce ARHL will also delay / reduce age-related vestibular dysfunction (ARVD). This is tested in

Aim 2A. Aim 2B will test if noise overstimulation given in youth will have a comparable influence on ARVD

as we see with ARHL, and result in an acceleration and enhancement of age-related vestibular

dysfunction. This would lead to later studies testing treatments.

Grant Number: 5I01RX004226-03
NIH Institute/Center: VA

Principal Investigator: Richard Altschuler

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →